← Back to Search

Behavioral Intervention

Differentiated Box for Colorectal Cancer

N/A

Waitlist Available

Led By Shivan Mehta, MD

Research Sponsored by Abramson Cancer Center at Penn Medicine

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 6 months

Awards & highlights

Study Summary

This trial will test different ways to increase the number of people who get screened for colorectal cancer, including mailing them a FIT kit and sending reminders.

Eligible Conditions

Colorectal Cancer
Colon Cancer

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 6 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~6 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Secondary outcome measures

Colorectal Cancer (CRC) Screening Completion (any)

FIT Completion

FIT Positive Follow-up Completion

+1 more

Trial Design

8Treatment groups

Experimental Treatment

Group I: Arm 8: Standard Mail + No Text + No ReminderExperimental Treatment3 Interventions

Standard Mail + No Text + No Reminder

Group II: Arm 7: Standard Mail + No Text + ReminderExperimental Treatment3 Interventions

Group III: Arm 6: Standard Mail + Text + No ReminderExperimental Treatment3 Interventions

Standard Mail + Text + No Reminder

Group IV: Arm 5: Standard Mail + Text + ReminderExperimental Treatment3 Interventions

Standard Mail + Text + Reminder

Group V: Arm 4: Box + No Text + No ReminderExperimental Treatment3 Interventions

Box + No Text + No Reminder

Group VI: Arm 3: Box + No Text + ReminderExperimental Treatment3 Interventions

Box + No Text + Reminder

Group VII: Arm 2: Box + Text + No ReminderExperimental Treatment3 Interventions

Box + Text + No Reminder

Group VIII: Arm 1: Box + Text + ReminderExperimental Treatment3 Interventions

Box + Text + Reminder

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Differentiated Box

2022

N/A

~5460

Standard Mail

2022

N/A

~5460

Text

2022

N/A

~5500

No Text

2022

N/A

~5460

Reminder

2022

N/A

~311170

No Reminder

2022

N/A

~5460

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Abramson Cancer Center at Penn MedicineLead Sponsor

387 Previous Clinical Trials

140,204 Total Patients Enrolled

Abramson Cancer Center of the University of PennsylvaniaLead Sponsor

359 Previous Clinical Trials

99,604 Total Patients Enrolled

Shivan Mehta, MDPrincipal InvestigatorUniversity of Pennsylvania

15 Previous Clinical Trials

72,207 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is aged persons' participation accepted in this clinical investigation?

"This medical trial only accepts patients aged between 50 to 74. However, there are additional trials that cater to those under 18 and over 65; 43 studies for the former group and 1234 for the latter."

Answered by AI

Could I realistically take part in this research initiative?

"To be eligible to join this medical trial, prospective participants must have malignant neoplasm of the colon and fall within the age bracket between 50 and 74. There is a total capacity for 5460 patients in the study."

Answered by AI

Are there still opportunities for participants to get involved in this clinical trial?

"Clinicaltrials.gov reveals that, while posted on May 27th 2022 and last modified on November 8th 2022, this trial has now concluded patient recruitment. Despite not currently seeking participants for this particular investigation, 1252 other studies are actively enrolling patients at present."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Mailed FIT Outreach 2022

Shivan Mehta 2022. "Mailed FIT Outreach 2022". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05341622.